株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

疼痛管理用医薬品の世界市場:種類(オピオイド、NSAID(非ステロイド性抗炎症薬)、抗片頭痛薬、抗痙攣薬)、用途、地域/国別

Global Pain Management Drugs Market - Analysis By Type (Opioids, NSAIDs, Anti-Migraine, Anticonvulsants), By Application, By Region, By Country: Opportunities and Forecast 2011-2021

発行 Azoth Analytics 商品コード 496593
出版日 ページ情報 英文 180 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.38円で換算しております。
Back to Top
疼痛管理用医薬品の世界市場:種類(オピオイド、NSAID(非ステロイド性抗炎症薬)、抗片頭痛薬、抗痙攣薬)、用途、地域/国別 Global Pain Management Drugs Market - Analysis By Type (Opioids, NSAIDs, Anti-Migraine, Anticonvulsants), By Application, By Region, By Country: Opportunities and Forecast 2011-2021
出版日: 2017年04月30日 ページ情報: 英文 180 Pages
概要

当レポートでは、疼痛管理用医薬品の世界市場について調査し、種類・用途・地域別に市場規模や収益を検証・推計するほか、市場成長への各種影響要因や、市場の動向、主要企業のプロファイルなどをまとめています。

第1章 調査手法

第2章 エグゼクティブサマリー

第3章 戦略提言

第4章 疼痛管理用医薬品市場の展望

第5章 疼痛管理用医薬品市場:成長と予測

  • 金額別(実績値)
  • 金額別(予測値)

第6章 疼痛管理用医薬品市場:地域別

  • 市場規模:地域別(実績値・予測値)
  • 市場規模:種類別(実績値・予測値)
  • 市場規模:用途別(実績値・予測値)
  • 種類別(実績値・予測値)
    • NSAID(非ステロイド性抗炎症薬)
    • オピオイド
    • 抗片頭痛薬
    • 抗痙攣薬

第7章 北米の疼痛管理用医薬品市場

  • 金額ベース(実績値・予測値)

第8章 北米の疼痛管理用医薬品市場:国別

  • 市場規模:国別(実績値・予測値)

第9章 北米の疼痛管理用医薬品市場:種類別

  • 市場規模:種類別(実績値・予測値)
  • 北米市場:金額・国別(実績値・予測値)
  • 米国市場:金額・国別(実績値・予測値)
  • カナダ市:金額・国別(実績値・予測値)

第10章 欧州の疼痛管理用医薬品市場

  • 金額ベース(実績値・予測値)

第11章 欧州の疼痛管理用医薬品市場:国別

  • 市場規模:国別(実績値・予測値)

第12章 欧州の疼痛管理用医薬品市場:種類別

  • 市場規模:種類別(実績値・予測値)
  • 欧州市場:金額・国別(実績値・予測値)
  • フランス市場:金額・国別(実績値・予測値)

第13章 アジア太平洋の疼痛管理用医薬品市場

  • 金額ベース(実績値・予測値)

第14章 アジア太平洋の疼痛管理用医薬品市場:国別

  • 市場規模:国別(実績値・予測値)

第15章 アジア太平洋の疼痛管理用医薬品市場:種類別

  • 市場規模:種類別(実績値・予測値)
  • アジア太平洋市場:金額・国別(実績値・予測値)
  • 日本市場:金額・国別(実績値・予測値)
  • 中国市場:金額・国別(実績値・予測値)
  • インド市場:金額・国別(実績値・予測値)

第16章 ラテンアメリカの疼痛管理用医薬品市場

  • 金額ベース(実績値・予測値)

第17章 ラテンアメリカの疼痛管理用医薬品市場:国別

  • 市場規模:国別(実績値・予測値)

第18章 ラテンアメリカの疼痛管理用医薬品市場:種類別

  • 市場規模:種類別(実績値・予測値)
  • ラテンアメリカ市場:金額・国別(実績値・予測値)
  • ブラジル市場:金額・国別(実績値・予測値)
  • メキシコ市場:金額・国別(実績値・予測値)

第19章 その他の地域の疼痛管理用医薬品市場

  • 金額ベース(実績値・予測値)

第20章 市場力学

  • 促進要因
  • 阻害要因
  • 市場動向

第21章 企業プロファイル

第22章 パイプライン分析

目次

Executive Summary

A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report titled “Global Pain Management Drugs Market: Analysis By Type (Opioids, NSAIDs, Anti-Migraine, Anticonvulsants), By Application, By Region, By Country: Opportunities and Forecast (2011-2021)” aims to present the analysis of the market of pain management drugs. The global market is projected to display a robust growth represented by a CAGR of 4.96% during 2016- 2021, chiefly driven by large number of drugs in pipeline, rising number of chronically ill patients, new reforms and regulations in the consumption of medical cannabis.

Over the recent years, the global pain management drugs industry has been growing rapidly with the increasing demand for drugs which are used for the treatment of chronic pain conditions of neck, lower back, shoulders, post-operative pain, and pain during the sports injuries. Globally, the growth in the pain management drugs market is driven by large number of chronically ill patients, rise in global incidences of cancer and strong presence of pipeline drugs used for chronically ill conditions.

According to Azoth Analytics research report, “Global Pain Management Drugs Market: Analysis By Type (Opioids, NSAIDs, Anti-Migraine, Anticonvulsants), By Application, By Region, By Country: Opportunities and Forecast (2011-2021)” the global market is projected to display a robust growth with a CAGR of 4.96% during 2016- 2021.

The report titled “Global Pain Management Drugs Market: Analysis By Type (Opioids, NSAIDs, Anti-Migraine, Anticonvulsants), By Application, By Region, By Country: Opportunities and Forecast (2011-2021)” has covered and analysed the potential of Global Pain Management Drugs Market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global food service equipment market. Additionally, the report also highlights market entry strategies for various companies across the globe.

Scope of the Report

Global Market (Actual Period: 2011-2015, Forecast Period: 2016E-2021F)

  • Pain Management Drugs Market
  • By Type of Drugs
  • Application Market
  • Drug Pipeline - By Developer, Phase, Indication and Status

Regional Markets - N. America, Europe, APAC, Latin America, RoW (Actual Period: 2011-2015, Forecast Period: 2016E-2021F)

  • Pain Management Drugs Market
  • By Type of Drugs

Country Analysis - US, Canada, UK, Germany, France, Japan, China, India, Brazil, Mexico (Actual Period: 2011-2015, Forecast Period: 2016E-2021F)

  • Pain Management Drugs Market

Other Report Highlights

  • Market Dynamics - Trends, Drivers, Challenges
  • Policy and Regulation
  • Company Analysis - Endo Pharmaceuticals, AstraZeneca, Novartis , Purdue Pharma, GSK, Tetra Bio Pharma, Allergen, Boehringer-Ingelheim, Sanofi,Pfizer

Customization of the Report

The report could be customized according to the client's specific research requirements. No additional cost will be required to pay for limited additional research.

Table of Contents

1. Research Methodology

2. Executive Summary

3. Strategic Recommendation

  • 3.1. Abuse Deterrent Opioids will create new growth opportunities
  • 3.2. Developing countries will provide huge acceptance for the generic drugs

4. Pain Management Drugs Market Outlook

5. Global Pain Management Drugs Market: Growth and Forecast

  • 5.1. By Value(2011-2015)
  • 5.2. By Value(2011-2015)

6. Global Pain Management Drugs Market: By Region

  • 6.1. Global Pain Management Drugs Market Size, By Region
    • 6.1.1. Global Pain Management Drugs Market Size, By Region, 2015(%)
    • 6.1.2. Global Pain Management Drugs Market Size, By Region, 2021(%)
  • 6.2. Global Pain Management Drugs Market: By Type
    • 6.2.1. Global Pain Management Drugs Market Size, By Type, 2015(%)
    • 6.2.2. Global Pain Management Drugs Market Size, By Type, 2021(%)
  • 6.3. Global Pain Management Drugs Market: By Application
    • 6.3.1. Global Pain Management Drugs Market Size, By Application, 2015(%)
    • 6.3.2. Global Pain Management Drugs Market Size, By Application, 2021(%)
  • 6.4. Global Pain Management Drugs Market: By Type, NSAID
    • 6.4.1. By Value(2011-2015)
    • 6.4.2. By Value(2016-2021)
  • 6.5. Global Pain Management Drugs Market: By Type, Opioids
    • 6.5.1. By Value(2011-2015)
    • 6.5.2. By Value(2011-2015)
  • 6.6. Global Pain Management Drugs Market: By Type, Antimigraine
    • 6.6.1. By Value(2011-2015)
    • 6.6.2. By Value(2016-2021)
  • 6.7. Global Pain Management Drugs Market: By Type, Anticonvulsants
    • 6.7.1. By Value(2011-2015)
    • 6.7.2. By Value(2016-2021)

7. North America Pain Management Drugs Market

  • 7.1. By Value(2011-2015)
  • 7.2. By Value(2016-2021)

8. North America Pain Management Drugs Market, By Country

  • 8.1. North America Pain Management Drugs Market Size, By Country, 2015(%)
  • 8.2. North America Pain Management Drugs Market Size, By Country, 2021(%)

9. North America Pain Management Drugs Market: By Type

  • 9.1. North America Pain Management Drugs Market Size, By Type, 2015(%)
  • 9.2. North America Pain Management Drugs Market Size, By Type, 2021(%)
  • 9.3. North America Pain Management Drugs Market, By Country, By Value
    • 9.3.1. United States Pain Management Drugs Market, By Value-(2011-2015)
    • 9.3.2. United States Pain Management Drugs Market, By Value-(2016-2021)
    • 9.3.3. Canada Pain Management Drugs Market, By Value-(2011-15)
    • 9.3.4. Canada Pain Management Drugs Market, By Value-(2016-2021)

10. Europe Pain Management Drugs Market

  • 10.1. By Value(2011-2015)
  • 10.2. By Value(2016-2021)

11. Europe Pain Management Drugs Market, By Country

  • 11.1. Europe Pain Management Drugs Market Size, By Country, 2015(%)
  • 11.2. Europe Pain Management Drugs Market Size, By Country, 2021(%)

12. Europe Pain Management Drugs Market: By Type

  • 12.1. Europe Pain Management Drugs Market Size, By Type, 2015(%)
  • 12.2. Europe Pain Management Drugs Market Size, By Type, 2021(%)
  • 12.3. Europe Pain Management Drugs Market, By Country, By Value
    • 12.3.1. Germany Pain Management Drugs Market, By Value-(2011-2015)
    • 12.3.2. Germany Pain Management Drugs Market, By Value-(2016-2021)
    • 12.3.3. France Pain Management Drugs Market, By Value-(2011-2015)
  • 12.3. France Pain Management Drugs Market, By Value-(2016-2021)
    • 12.3.5. UK Pain Management Drugs Market, By Value-(2011-2015)
    • 12.3.6. UK Pain Management Drugs Market, By Value-(2011-2015)

13. Asia Pacific Pain Management Drugs Management Market

  • 13.1. By Value(2011-2015)
  • 13.2. By Value(2016-2021)

14. Asia Pacific Pain Management Drugs Market, By Country

  • 14.1. Asia Pacific Pain Management Drugs Market Size, By Country, 2015(%)
  • 14.2. Asia Pacific Pain Management Drugs Market Size, By Country, 2021(%)

15. Asia Pacific Drug Pain Management Market: By Type

  • 15.1. Asia Pacific Pain Management Drugs Market Size, By Type, 2015(%)
  • 15.2. Asia Pacific Pain Management Drugs Market Size, By Type, 2021)
  • 15.3. Asia Pacific Pain Management Drugs Market, By Country, By Value
    • 15.3.1. Japan Pain Management Drugs Market, By Value-(2011-2015)
    • 15.3.2. Japan Pain Management Drugs Market, By Value-(2016-2021)
    • 15.3.3. China Pain Management Drugs Market, By Value-(2011-2015)
    • 15.3.4. China Pain Management Drugs Market, By Value-(2016-2021)
    • 15.3.5. India Pain Management Drugs Market, By Value-(2011-2015)
    • 15.3.6. India Pain Management Drugs Market, By Value-(2016-2021)

16. Latin America Pain Management Drugs Market

  • 16.1. By Value(2011-2015)
  • 16.2. By Value(2016-2021)

17. Latin America Pain Management Drugs Market, By Country

  • 17.1. Latin America Pain Management Drugs Market Size, By Country, 2015(%)
  • 17.2. Latin America Pain Management Drugs Market Size, By Country, 2021(%)

18. Latin America Pain Management Drugs Market: By Type

  • 18.1. Latin America Pain Management Drugs Market Size, By Type, 2015(%)
  • 18.2. Latin America Pain Management Drugs Market Size, By Type, 2021(%)
  • 18.3. Latin America Pain Management Drugs Market, By Country, By Value
    • 18.3.1. Brazil Pain Management Drugs Market, By Value-(2011-2015)
    • 18.3.2. Brazil Pain Management Drugs Market, By Value-(2016-2021)
    • 18.3.3. Mexico Pain Management Drugs Market, By Value-(2011-2015)
    • 18.3.4. Mexico Pain Management Drugs Market, By Value-(2016-2021)

19. ROW Pain Management Drugs Market

  • 19.1. By Value(2011-2015)
  • 19.2. By Value(2016-2021)

20. Market Dynamics

  • 20.1. Drivers
  • 20.2. Challenges
  • 20.3. Trends

21. Company Profiles

  • 21.1. Astrazeneca plc
  • 21.2. Endo Pharmaceuticals
  • 21.3. Pfizer
  • 21.4. Novartis
  • 21.5. Purdue Pharma
  • 21.6. Allergan
  • 21.7. Boehringer Ingelheim
  • 21.8. Glaxosmithkline
  • 21.9. Sanofi
  • 21.10. Tetra Bio Pharma

22. Pipeline Analysis

List of Figures

  • Figure 1: Global Pain Management Drugs Market Size, By Value, 2011-2015(USD Billion)
  • Figure 2: National Healthcare Expenditure 2014-2020F
  • Figure 3: Medicare spending in USD Billions
  • Figure 4: Number of employees(in Millions) - enrolled in Medicare Program
  • Figure 5: Expenditure as a percentage of GDP
  • Figure 6: Global Pain Management Drugs Market Size, By Value, 2016E-2021F(USD Billion)
  • Figure 7: Global Pain Management Drugs Market, By Region -2015
  • Figure 8: Key Drivers
  • Figure 9: Global Pain Management Drugs Market, By Region -2021F
  • Figure 10: Key Drivers
  • Figure 11: Global Pain Management Drugs Market, By Type-2015
  • Figure 12: Key Drivers
  • Figure 13: Global Pain Management Drugs Market, By Type-2021F
  • Figure 14: Key Drivers
  • Figure 15: Global Pain Management Drugs Market, By Applications-2015
  • Figure 16: Key Drivers
  • Figure 17: Global Pain Management Drugs Market, By Applications- 2021F
  • Figure 18: Key Drivers
  • Figure 19: Global NSAID Drug Market Size, By Value, 2011-2015(USD Billion)
  • Figure 20: Best Buy NSAID Drug
  • Figure 21: Global NSAID Drug Market Size, By Value, 2016E-2021F(USD Billion)
  • Figure 22: Global Medical Opioid Market Size, By Value, 2011-2015(USD Billion)
  • Figure 23: United States - Hydromorphone Consumption(mg per capita)
  • Figure 24: United States -Fentanyl Consumption(mg per capita)
  • Figure 25: United States - Morphine Consumption(mg per capita)
  • Figure 26: United States -Methadone Consumption(mg per capita)
  • Figure 27: UK - Fentanyl Consumption(mg per capita)
  • Figure 28: UK - Hydromorphone Consumption(mg per capita
  • Figure 29: UK - Morphine Consumption(mg per capita)
  • Figure 30: UK -Methadone Consumption(mg per capita)
  • Figure 31: Global Medical Opioid Market Size, By Value, 2016E-2021F(USD Billion)
  • Figure 32: Global Anti-migraine Drug Market Size, By Value, 2011-2015(USD Billion)
  • Figure 33: Europe - Impact of Migraine Annual years of Healthy Life Cost(per 100,000 of people)
  • Figure 34: Global Anti-Migraine Market Size, By Value, 2016E-2021F(USD Billion)
  • Figure 35: Global Anticonvulsants Drug Market Size, By Value, 2011-2015(USD Billion)
  • Figure 36: Best Buy Anticonvulsants Drug
  • Figure 37: Global Anticonvulsants Drug Market Size, By Value, 2016E-2021F(USD Billion)
  • Figure 38: North America Pain Management Drugs Market Size, By Value, 2011-2015(USD Billion)
  • Figure 39: Medicare spending in USD Billions
  • Figure 40: North America Pain Management Drugs Market Size, By Value, 2016E-2021F(USD Billion)
  • Figure 41: North America Pain Management Drugs Market, By Country-2015
  • Figure 42: Key Drivers
  • Figure 43: North America Pain Management Drugs Market, By Country -2021
  • Figure 44: Key Drivers
  • Figure 45: North America Pain Management Drugs Market, By Type -2015
  • Figure 46: Key Drivers
  • Figure 47: North America Pain Management Drugs Market, By Type-2021
  • Figure 48: Key Drivers
  • Figure 49: United States Pain Management Drugs Market Size, By Value, 2011-2015(USD Billion)
  • Figure 50: Specialty Drug Spending in USA in USD Billion
  • Figure 51: Out of Pocket Expenditure in USD Billion
  • Figure 52: United States Pain Management Drugs Market Size, By Value, 2016-2021(USD Billion)
  • Figure 53: Canada Pain Management Drugs Market Size, By Value, 2011-2015(USD Billion)
  • Figure 54: Canada spending on healthcare
  • Figure 55: Canada spending on prescription based drugs
  • Figure 56: Canada Pain Management Drugs Market Size, By Value, 2016-2021(USD Billion)
  • Figure 57: Europe Pain Management Drugs Market Size, By Value, 2011-2015(USD Billion)
  • Figure 58: Europe Healthcare spending as percent of GDP
  • Figure 59: Europe spending on prescription based drugs
  • Figure 60: Europe Pain Management Drugs Market Size, By Value, 2016-2021(USD Billion)
  • Figure 61: Europe Pain Management Drugs Market, By Country-2015
  • Figure 62: Key Drivers
  • Figure 63: Europe Pain Management Market, By Country -2021
  • Figure 64: Key Drivers
  • Figure 65: Europe Pain Management Drugs Market, By Type -2015
  • Figure 66: Key Drivers
  • Figure 67: Europe Pain Management Drugs Market, By Type-2021
  • Figure 68: Key Drivers
  • Figure 69: Germany Pain Management Drugs Market Size, By Value, 2011-2015(USD Billion)
  • Figure 70: Germany - Sales of Generic Drugs in USD Billion
  • Figure 71: Germany - Percentage share of prescription drugs sold by retail pharmacy -2015
  • Figure 72: Germany Pain Management Drugs Market Size, By Value, 2016-2021(USD Billion)
  • Figure 73: France Pain Management Drugs Market Size, By Value, 2011-2015(USD Billion)
  • Figure 74: France - Percentage share of Generic drugs(By Volume)
  • Figure 75: France - Percentage share of Generic drugs in Re-imbursed Pharmaceutical Market(By Value)
  • Figure 76: France Pain Management Drugs Market Size, By Value, 2016-2021(USD Billion)
  • Figure 77: UK Pain Management Drugs Market Size, By Value, 2011-2015(USD Billion)
  • Figure 78: UK- Healthcare expenditure as percentage of GDP
  • Figure 79: Key Drivers
  • Figure 80: UK Pain Management Drugs Market Size, By Value, 2016-2021(USD Billion)
  • Figure 81: Asia Pacific Pain Management Drugs Market Size, By Value, 2011-2015(USD Billion)
  • Figure 82: Asia Pacific Pain Management Drugs Market Size, By Value, 2016E-2021F(USD Billion)
  • Figure 83: Asia Pacific Pain Management Drugs Market, By Country-2015
  • Figure 84: Key Drivers
  • Figure 85: Asia Pacific Pain Management Drugs Market, By Country -2021
  • Figure 86: Key Drivers
  • Figure 87: Asia Pacific Pain Management Drugs Market, By Type -2015
  • Figure 88: Key Drivers
  • Figure 89: Asia Pacific Pain Management Drugs Market, By Type-2021
  • Figure 90: Key Drivers
  • Figure 91: Japan Pain Management Drugs Market Size, By Value, 2011-2015(USD Billion)
  • Figure 92: Japan- Sales of Prescription based drugs in USD Billion
  • Figure 93: Japan - Opioid(Morphine) Consumption in mg per capita
  • Figure 94: Japan- Fentanyl Opioid Consumption in mg per capita
  • Figure 95: Japan -Oxycodone Opioid Consumption in mg per capita
  • Figure 96: Japan- Fentanyl Opioid Consumption in mg per capita
  • Figure 97: China Pain Management Drugs Market Size, By Value, 2011-2015(USD Billion)
  • Figure 98: China - Revenue from pharmaceutical sector(in USD Billion)
  • Figure 99: China - Aging Population as Percentage of total population
  • Figure 100: China - Generic Drug Sales in RMB Billion
  • Figure 101: China- Patented Drug Sales in RMB Billion
  • Figure 102: China Pain Management Drugs Market Size, By Value, 2016-2021(USD Billion)
  • Figure 103: China- Import and Export of Pharmaceutical Products
  • Figure 104: India Pain Management Drugs Market Size, By Value, 2011-2015(USD Billion)
  • Figure 105: Chronic pain in India
  • Figure 106: India - Revenue from pharmaceutical sector
  • Figure 107: India - Percentage Share of Pharmaceutical Segments- 2015
  • Figure 108: India Pain Management Drugs Market Size, By Value, 2016-2021(USD Billion)
  • Figure 109: Latin America Pain Management Drugs Market Size, By Value, 2011-2015(USD Billion)
  • Figure 110: Latin America Pain Management Drugs Market Size, By Value, 2016-2021(USD Billion)
  • Figure 111: Latin America Pain Management Drugs Market, By Country-2015
  • Figure 112: Key Drivers
  • Figure 113: Latin America Pain Management Drugs Market, By Country -2021
  • Figure 114: Key Drivers
  • Figure 115: Latin America Pain Management Drugs Market, By Type -2015
  • Figure 116: Key Drivers
  • Figure 117: Latin America Pain Management Drugs Market, By Type-2021
  • Figure 118: Key Drivers
  • Figure 119: Brazil Pain Management Drugs Market Size, By Value, 2011-2015(USD Billion)
  • Figure 120: Brazil - Healthcare expenditure as a percentage of GDP
  • Figure 121: Brazil - Percentage Share of Specialty and Traditional Medicine -2015
  • Figure 122: Brazil Pain Management Drugs Market Size, By Value, 2016E-2021F(USD Billion
  • Figure 123: Mexico Pain Management Drugs Market Size, By Value, 2011-2015(USD Billion)
  • Figure 124: Mexico Pain Management Drugs Market Size, By Value, 2016E-2021F(USD Billion)
  • Figure 125: ROW Pain Management Drugs Market Size, By Value, 2011-2015(USD Billion)
  • Figure 126: Government share in healthcare spending in GCC countries
  • Figure 127: Healthcare spending in GCC Countries in USD Billion
  • Figure 128: South Africa - Health Financing Options in Total Healthcare Expenditure- 2015
  • Figure 129: ROW Pain Management Drugs Market Size, By Value, 2016E-2021F(USD Billion)
  • Figure 130: Africa - Growth in Pharma Segments in USD Billion
  • Figure 131: Astrazeneca Global Product Sales - By Therapy Areas - 2015
  • Figure 132: Astrazeneca Global Product Sales - By Therapy Areas - 2014
  • Figure 133: Astrazeneca Product Sales - By Geographic Markets - 2015
  • Figure 134: Astrazeneca Product Sales - By Geographic Markets - 2014
  • Figure 135: Endo Pharmaceuticals Segment Sales - 2015
  • Figure 136: Endo Pharmaceuticals Segment Sales - 2014
  • Figure 137: Pfizer Segment Sales Worldwide - 2015
  • Figure 138: Pfizer Segment Sales Worldwide - 2014
  • Figure 139: Tetra Bio Pharma Pipeline
  • Figure 140: Trevena Pipeline
Back to Top